Advertisement
Screener

Definium Therapeutics, Inc. (DFTX) Debt Instrument, Fee Amount

2.8 / 5 stars · 68/120 Roast Me

Definium Therapeutics, Inc. Debt Instrument, Fee Amount

Definium Therapeutics, Inc. (DFTX) had Debt Instrument, Fee Amount of $656.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Debt › Debt Instruments

us-gaap:DebtInstrumentFeeAmount · last filed 2026-08-06

  • 2026-06-30: Debt Instrument, Fee Amount $656.00K.
  • 2026-03-31: Debt Instrument, Fee Amount $525.00K.
  • 2025-12-31: Debt Instrument, Fee Amount $394.00K.
  • 2025-09-30: Debt Instrument, Fee Amount $263.00K.
Period endDebt Instrument, Fee Amount
2026-06-30$656.00K
10-Q · filed 2026-08-06
2026-03-31$525.00K
10-Q · filed 2026-05-07
2025-12-31$394.00K
10-K · filed 2026-02-26
2025-09-30$263.00K
10-Q · filed 2025-11-06
2025-06-30$131.00K
10-Q · filed 2025-07-31
2025-03-31$603.00K
10-Q · filed 2025-05-08
2024-12-31$482.00K
10-K · filed 2025-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cronos Group Inc. (CRON)$1.223B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B